| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/13/2013 | WO2013055825A3 Guanidinyl-substituted polyamides useful for treating human papilloma virus |
| 06/13/2013 | WO2013054204A3 A process for making an intermediate of cabazitaxel |
| 06/13/2013 | WO2013054147A3 Erlotinib salts |
| 06/13/2013 | WO2013048169A3 Method for preparing taxane derivatives |
| 06/13/2013 | WO2013043232A3 8-ethyl-6-(aryl)pyrido [2,3-d]pyrimidin-7(8h) -ones for the treatment of nervous system disorders and cancer |
| 06/13/2013 | WO2013041967A9 Compositions and methods for treating presbyopia, mild hyperopia, and irregular astigmatism |
| 06/13/2013 | WO2013038268A8 Tamper resistant immediate release formulations |
| 06/13/2013 | WO2013029057A3 Compositions and methods for treating neurodegenerative disease |
| 06/13/2013 | WO2013025064A3 Anti-cancer composition comprising wnt decoy receptors |
| 06/13/2013 | WO2013022312A3 Pharmaceutical composition for preventing or treating diabetes or fatty liver containing a cyp4a inhibitor as an active ingredient |
| 06/13/2013 | WO2013022257A3 Composition for preventing and treating non-small cell lung cancer, containing pyrazino-triazine derivatives |
| 06/13/2013 | WO2013022238A3 Tricyclic glycosylated derivative compound, a production method therefor, and an immunosuppressant pharmaceutical composition comprising a tacrolimus glycosylation derivative |
| 06/13/2013 | WO2013020024A3 Maleimide compounds and methods of treatment |
| 06/13/2013 | WO2013017715A3 Quinolyl nitrones |
| 06/13/2013 | WO2013015657A3 Novel compound having angiogenesis inhibitory activity, method for preparing same, and pharmaceutical composition comprising same |
| 06/13/2013 | WO2013009910A3 Eosinophil peroxidase compositions and methods of their use |
| 06/13/2013 | WO2012177893A3 Trpm8 antagonists and their use in treatments |
| 06/13/2013 | WO2012177593A3 Method for treating obesity |
| 06/13/2013 | WO2012173677A3 Anticancer therapeutic agents |
| 06/13/2013 | WO2012170664A3 Methods of cancer treatment and prevention through the modulation of sirt4 activity |
| 06/13/2013 | WO2012170573A3 New taccalonolide microtubule stabilizers |
| 06/13/2013 | WO2012159085A3 Compositions and methods for treating and preventing cancer by targeting and inhibiting cancer stem cells |
| 06/13/2013 | WO2012031196A9 4- { [ ( pyridin- 3 - yl -methyl) aminocarbonyl] amino} benzene - sulfone derivatives as nampt inhibitors for therapy of diseases such as cancer |
| 06/13/2013 | WO2009108755A3 Pharmaceutical combinations for the treatment of cancer |
| 06/13/2013 | US20130150964 Biodegradable polyurethane/urea compositions |
| 06/13/2013 | US20130150649 Sensitization of tumor cells to radiation therapy through administration of endothelin agonists |
| 06/13/2013 | US20130150628 Pharmaceutical composition comprising a curcumin derivative |
| 06/13/2013 | US20130150598 Use of 25-hydroxy-vitamin d3 to affect human muscle physiology |
| 06/13/2013 | US20130150550 Antibiotic-Bound Poly(Caprolactone) Polymer |
| 06/13/2013 | US20130150455 Method for treating mechanical allodynia comprising administration of eugenol |
| 06/13/2013 | US20130150449 1-amino-alkylcyclohexane derivatives for the treatment of inflammatory skin diseases |
| 06/13/2013 | US20130150446 Anti-inflammatory actions of neuroprotectin d1/protectin d1 and its natural stereoisomers |
| 06/13/2013 | US20130150444 Modified release compositions of magnesium valproate |
| 06/13/2013 | US20130150443 Diene compounds for use in human epidermal cell repair, and pharmaceutical and cosmetic compositions containing them |
| 06/13/2013 | US20130150442 Oligo-benzamide compounds and their use in treating cancers |
| 06/13/2013 | US20130150440 Use of bis [thiohydrazide amide] compounds such as elesclomol for treating cancers |
| 06/13/2013 | US20130150438 Use of low-dose ladostigil for neuroprotection |
| 06/13/2013 | US20130150437 Naphthoquinones for disease therapies |
| 06/13/2013 | US20130150436 Polyacetylene compound, an extract containing the same and application thereof |
| 06/13/2013 | US20130150435 Method for treating hepatitis c |
| 06/13/2013 | US20130150434 Methods of using low-dose doxepin for the improvement of sleep |
| 06/13/2013 | US20130150430 Methods for Impairing the P53/HDM2 Auto-Regulatory Loop in Multiple Myeloma Development Using mIR-192, mIR-194 and mIR-215 |
| 06/13/2013 | US20130150428 Mir27b is a novel target for treatment of liver fibrosis |
| 06/13/2013 | US20130150427 Regulation of metabolism by mir-378 |
| 06/13/2013 | US20130150425 Antisense modulation of gccr expression |
| 06/13/2013 | US20130150423 Topical therapy for migraine |
| 06/13/2013 | US20130150421 Combination of 4-benzamide and a nmda receptor antagonist and pharmaceutical compositions containing the same |
| 06/13/2013 | US20130150419 4-methylpyrazole formulations for inhibiting ethanol intolerance |
| 06/13/2013 | US20130150418 Apparatus and method for the treatment of abnormal uterine bleeding |
| 06/13/2013 | US20130150412 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive mglur2-receptor |
| 06/13/2013 | US20130150410 Controlled Release Ion Channel Modulator Compositions and Methods for the Treatment of Otic Disorders |
| 06/13/2013 | US20130150409 Novel trpv3 modulators |
| 06/13/2013 | US20130150408 Substituted dioxopiperidinyl phthalimide derivatives |
| 06/13/2013 | US20130150406 Hydrobromide salt of pridopidine |
| 06/13/2013 | US20130150405 Iminosugars and methods of treating togaviral diseases |
| 06/13/2013 | US20130150404 Biphenyl derivatives |
| 06/13/2013 | US20130150402 Pharmaceutical composition for treating overactive bladder |
| 06/13/2013 | US20130150399 Inhibitors of the unfolded protein response and methods for their use |
| 06/13/2013 | US20130150397 Rapamycin composition |
| 06/13/2013 | US20130150396 Solubilization and Bioavailability of Acetaminophen |
| 06/13/2013 | US20130150391 Piperidinyl Pyrimidine Amides As KV7 Potassium Channel Openers |
| 06/13/2013 | US20130150389 Etravirine Formulations and Uses Thereof |
| 06/13/2013 | US20130150386 Methods for the treatment of lung cancer |
| 06/13/2013 | US20130150385 Cancer therapy using a combination of a hsp90 inhibitory compounds and a egfr inhibitor |
| 06/13/2013 | US20130150384 Method for treatment of brain cancers |
| 06/13/2013 | US20130150383 Novel compounds |
| 06/13/2013 | US20130150382 Novel pharmaceutical dosage forms comprising valganciclovir hydrochloride |
| 06/13/2013 | US20130150381 Phenylthioacetate compounds, compositions and methods of use |
| 06/13/2013 | US20130150379 Methods of treatment and prevention of neurodegenerative diseases and disorders |
| 06/13/2013 | US20130150376 Novel Sultam Compounds |
| 06/13/2013 | US20130150375 GEPIRONE-ER TREATMENT OF MAJOR DEPRESSION IN PATIENTS TAKING NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDs) |
| 06/13/2013 | US20130150374 Arylalkylamine compound and process for preparing the same |
| 06/13/2013 | US20130150369 Benzotriazine Oxides as Drugs Targeting Mycobacterium Tuberculosis |
| 06/13/2013 | US20130150364 Heterocyclic compound |
| 06/13/2013 | US20130150363 Method of Treating Cancer Using a cMET and AXL Inhibitor and an ErbB Inhibitor |
| 06/13/2013 | US20130150362 NOVEL PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS |
| 06/13/2013 | US20130150359 Pyrazoloquinolines |
| 06/13/2013 | US20130150356 Acyl Piperazine Derivatives as TTX-S Blockers |
| 06/13/2013 | US20130150351 Methods and compositions for treating a subject for central nervous system (cns) injury |
| 06/13/2013 | US20130150349 2,4-pyrimidinediamine compounds and their uses |
| 06/13/2013 | US20130150346 Use of FAAH Inhibitors for Treating Parkinson's Disease and Restless Legs Syndrome |
| 06/13/2013 | US20130150338 Anti-dandruff shampoo |
| 06/13/2013 | US20130150336 Methods For Reducing Superoxide Anions in Eukaryotic Organisms |
| 06/13/2013 | US20130150335 Paclitaxel/steroidal complex |
| 06/13/2013 | US20130150334 Topical formulation for administering a compound |
| 06/13/2013 | US20130150330 Decoquinate prodrugs |
| 06/13/2013 | US20130150327 Composition for preventing hair loss or stimulating hair growth |
| 06/13/2013 | US20130150325 3-(Fluorovinyl)pyrazoles and their use |
| 06/13/2013 | US20130150324 Efficient lipid delivery to human tear film using a salt-sensitive emulsion system |
| 06/13/2013 | US20130150323 Use of oral heparin preparations to treat urinary tract diseases and conditions |
| 06/13/2013 | US20130150321 Acetaminophen/Ibuprofen Combinations And Method For Their Use |
| 06/13/2013 | US20130150320 Method of inhibiting increase of immunoglobulin a |
| 06/13/2013 | US20130150317 Compounds for the treatment of renal cell carcinoma |
| 06/13/2013 | US20130150316 Levocarrimycin, pharmaceutical compositions, preparation methods and uses thereof |
| 06/13/2013 | US20130150315 Anti-Protozoal for Apicomplexan Protozoa |
| 06/13/2013 | US20130150312 Topical antiviral formulations |
| 06/13/2013 | US20130150311 Mixed poloxamer excipients |
| 06/13/2013 | US20130150310 Compositions and Methods for Treatment of Cancer |
| 06/13/2013 | US20130150306 Milk-based nutritional compositions containing lactoferrin and uses thereof |
| 06/13/2013 | US20130150292 Soft Protease Inhibitors and Pro-Soft Forms Thereof |